Proviral insertions at the viral insertion site Lvis1 occur frequently in B-and T-cell leukemias and lymphomas in AKXD mice and activate two nearby genes, the divergent homeobox gene Hex and the kinesin-related spindle protein gene Eg5. To determine whether Hex misexpression results in the altered differentiation or neoplastic transformation of hematopoietic lineages, we have transplanted mice with bone marrow cells transduced with retrovirus containing the Hex coding region. High levels of Hex expression in hematopoietic precursor cells inhibit contribution to mature blood cell lineages by these precursors. Hex bone marrow transplant recipient mice also develop hematologic neoplasms that appear to originate in the bone marrow. The tumors have clonal rearrangements of the TCR locus, are Thy1 þ , and are
Introduction
Homeodomain-containing transcription factors play important roles in the normal development of the hematopoietic system, and deregulated expression of homeodomain genes has been found to be a common feature of myeloid and lymphoid neoplasms in humans (Thorsteinsdottir et al., 1997) . Chromosomal translocations commonly found in human leukemias and lymphomas often result in the ectopic activation of homeodomain genes or their regulators or the generation of chimeric fusion loci from these genes (Look, 1997) . Homeodomain-containing genes are also common targets of proviral insertions in retrovirus-induced murine hematologic neoplasms (Owens and Hawley, 2002) . The oncogenic potential of several of these genes has been established by the analysis of transgenic mice and retrovirally transduced bone marrow transplant mouse models in which these putative oncogenes are overexpressed in the hematopoietic compartment (Owens and Hawley, 2002) .
Insertional mutagenesis has proved to be a valuable strategy in the identification of genes involved in the onset of hematopoietic neoplasms in mice (Jonkers and Berns, 1996) . Mobile DNA elements such as murine retroviruses can induce somatic insertion mutations that activate proto-oncogenes or disrupt tumor suppressor genes, and common sites of proviral insertion can be used to identify genomic loci that are frequently altered in mouse tumors. Among the most common proviral insertion sites identified in mouse leukemias and lymphomas is Lvis1; insertions at Lvis1 are present in a large proportion of such neoplasms in tumor-prone AKXD and BXH-2 recombinant inbred (R1) mouse strains (Hansen and Justice, 1999; Suzuki et al., 2002) . Two genes in the vicinity of the Lvis1 insertion site, the homeobox gene Hex and the kinesin-related spindle motor protein Eg5, are upregulated in tumors with Lvis1 insertions, suggesting a role for these genes singly or cooperatively in the onset of blood cell-derived neoplasms in AKXD mice (Hansen and Justice, 1999) .
Hex, also known as Prh, was first identified in screens to identify novel homeobox genes in hematopoietic cell lines and primary chicken, mouse, and human hematopoietic cells (Crompton et al., 1992; Bedford et al., 1993; Hromas et al., 1993) . Homologues have subsequently been identified in Xenopus, rat, and zebrafish (Newman et al., 1997; Ho et al., 1999; Tanaka et al., 1999) . Hex is a divergent homeobox gene whose homeodomain shares 46% sequence identity with that of the Drosophila Antennapedia gene. During mouse embryogenesis, Hex is first expressed in the primitive endoderm and subsequently in definitive endoderm (Thomas et al., 1998) . Later expression is detectable in nascent blood islands in the visceral yolk sac and in endothelial cell precursors (Thomas et al., 1998) as well as in a variety of endoderm-derived organs (Bogue et al., 2000) . Mouse embryos homozygous for Hex-null mutations die between 10.5 and 15.5 d.p.c with defects in liver, thyroid, and forebrain development as well as in monocyte development (Keng et al., 2000; MartinezBarbera et al., 2000) . In the adult mouse, Hex expression can be detected in lung, liver, and thyroid (Bogue et al., 2000) . In the hematopoietic system, Hex is expressed in pluripotent progenitor, erythromyeloid and B-cell lineages but not in T-cell lineages (Bedford et al., 1993; Manfioletti et al., 1995) . Hex expression is downregulated during terminal differentiation of B cells, suggesting that Hex is involved in B-cell development (Manfioletti et al., 1995) . Mice generated from chimeric blastocysts composed of HexÀ/À and RAGÀ/À ES cells are defective in normal B-cell development and function but have normal T-cell differentiation (Bogue et al., 2003) . Recently, it has been demonstrated that transgene-driven expression of Hex in thymocytes disrupts normal T-cell development, resulting in fewer double-positive and more CD8 þ cells in the thymus and decreased numbers of T cells in the periphery (Mack et al., 2002) .
To determine whether Hex is an oncogene that induces blood cell-derived neoplasms, we have carried out transplants of bone marrow transduced with a retroviral construct containing the Hex coding region to determine the effect of Hex overexpression on hematopoietic differentiation and the incidence of lymphoid cancers in recipient mice. Our results indicate that progenitor hematopoietic cells overexpressing Hex at high levels are incapable of contributing to mature blood cell lineages. Additionally, lower levels of Hex misexpression in hematopoietic progenitors induce immature T lymphocyte-derived lymphomas in bone marrow recipient mice. Our results demonstrate that Hex can act as an oncogene in lymphoid cells and suggest that hematopoietic progenitor cell contribution to mature blood cell lineages is sensitive to the levels of Hex expression.
Results

Generation of recipient mice transplanted with MSCV-Hex:IRES:GFP virus
Murine stem cell virus (MSCV)-based retroviral vectors modified to contain an IRES:GFP cassette are commonly used to express ectopically genes of interest in hematopoietic stem cells in bone marrow transduction and transplantation assays. The MSCV LTR promoter drives high levels of expression in blood cells (Hawley et al., 1994) , while the expression of GFP from the virusderived bicistronic transcript permits the identification of cells with transcriptionally active viral insertions. We established that both the control MSCV-IRES:GFP construct and the MSCV-Hex:IRES:GFP constructderived virus particles produce expected proviral integrations as determined by Southern blot analysis of NIH3T3 cells transduced with virus preparations (Figure 1b) . Additionally, we confirmed the production of Hex protein from the MSCV-Hex:IRES:GFP construct by Western blot analysis of cell lysates from transfected Phoenix packaging cells with Hex-specific polyclonal serum (Figure 1c ). We transduced bone marrow from C57BL/6 CD45.1 donors separately with MSCV-IRES:GFP and MSCV-Hex:IRES:GFP virus preparations. Flow cytometric analysis of transduced bone marrow prior to transplantation confirmed equivalent numbers of GFP-positive cells and equivalent levels of GFP fluorescence in MSCV-Hex:IRES:GFPand MSCV-IRES:GFP-transduced samples (Figure 1d ), indicating that virus preparations from both constructs transduced bone marrow cells and were expressed in these cells at equivalent levels.
We transplanted virus-transduced marrow into irradiated C57BL/6 CD45.2 recipients and determined the efficiency of hematopoietic reconstitution in recipient mice 4 weeks post-transplantation by analysing leukocytes in peripheral blood samples for expression of the donor CD45.1 surface marker. (Table 1) . MSCV-Hex:IRES:GFP proviral insertions could be detected at low levels in genomic DNA from thymus, spleen, and bone marrow of transplanted mice by Southern blotting and by provirus-specific PCR, however, indicating that virus-transduced hematopoietic cells do persist in low numbers in these mice (data not shown).
Spontaneous incidence of lymphomas in Hex-transduced bone marrow recipients
We aged 27 Hex-transduced bone marrow recipient mice and 23 control-transplant mice to determine the incidence of hematopoietic neoplasms in the Hextransplant group. Beginning at 25 weeks post-transplantation, Hex-transduced bone marrow recipient mice began to display signs of systemic illness, including cachexia, labored breathing, and poor grooming, and were killed when moribund. Necropsy of these mice commonly revealed enlargement of the spleen and the thymus, with less common involvement of the lymph nodes. Additionally, some mice displayed enlarged and pale or mottled livers and kidneys. By 35 weeks posttransplantation, 63% of the MSCV-Hex:IRES:GFP transplant recipient mice had been killed or had died, with a mean time of death of 26.8 weeks posttransplantation. Mortality was significantly lower among control mice at 13% (Figure 2 ; Mantel-Cox log-rank test, Po0.05) and necropsy of dead control mice did not reveal gross pathology similar to that seen in mice from the experimental group. Histologic studies of tissues from moribund MSCVHex:IRES:GFP recipients revealed a striking proliferation of lymphoblasts in the bone marrow of the sternum (Figure 3a) . The cytology was fully consistent with lymphoblasts seen in precursor T-cell and B-cell lymphoblastic lymphoma/leukemia . In all cases examined, blasts eroded through the bone and spread into the peristernal musculature (Figure 3b ). Affected lymph nodes were filled with lymphoblasts identical to those seen in bone marrow (Figure 3c ). Perivascular infiltrates were observed in liver (Figure 3d) , kidney, and lung (not shown). The spleen exhibited loss of normal architecture (Figure 3e ) and diffuse infiltration of the red and white pulp with lymphoblasts ( Figure 3f ).
Characterization of tumors from Hex-transduced bone marrow recipients
To determine the lineage of the tumors in Hextransplant recipient mice and to confirm their clonal origin, we prepared genomic DNA from a number of affected organs from each mouse and analysed these samples for rearrangements of the T-cell receptor (TCR) b chain locus using a probe corresponding to the TCR Jb2 region of this locus. Tumors from all mice were positive for clonal TCR rearrangements, confirming that they were derived from the T-lymphocyte lineage and were mono-or oligoclonal in origin (Figure 4) . Additionally, all analysed samples from each mouse had identical patterns of TCR rearrangements, indicating that all tumors in each mouse shared a common clonal origin.
We analysed single-cell suspensions from hematopoietic organs of killed transplant recipient mice for their cell surface marker phenotype. In all samples, the vast majority of cells were CD45.1 þ , indicating that the tumors had arisen from donor-derived hematopoietic cells. GFP þ cells were absent or present in very low numbers in most tumors (Figure 5a ), suggesting that proviral insertions in tumor cells were either transcriptionally silent or were being expressed at very low levels. A large proportion of CD45.1 þ cells in all samples, including bone marrow, were also Thy1 þ (Figure 5b ), confirming that the tumors arising in MSCV-Hex: IRES:GFP transplant recipient mice were of T-cell origin. The tumors were variable in their expression pattern of CD4 and CD8, with some tumors consisting predominantly of double-positive cells and some of a mixture of double-negative, double-positive, and CD4 or CD8 single-positive cells (Figure 5c ).
Analysis of proviral insertions in Hex-transplant mice
To confirm that tumors arising in Hex-transplant mice were induced by expression of Hex from proviral insertions, we analysed these tumors for the presence of intact and clonal proviral insertions and for the expression of provirus-derived Hex transcript. We first examined tumors for the presence of intact provirus by Southern blotting of NheI-digested DNA preparations. All tumor samples analysed were positive for the intact 3.8 kb proviral fragment released by NheI digestion (Figure 6a ). Additionally, we analysed proviral insertions for clonality by digesting tumor DNA with restriction enzymes that cut at a unique site within the proviral sequence. All tumor samples analysed displayed one or two provirus-derived bands, indicating that the tumors arose clonally from cells with one or two proviral insertions (Figure 6b) . As with the analysis of TCR rearrangements in tumors, the common pattern of proviral insertions in all samples from each mouse indicates the clonal origin of tumor cells disseminated to various organs.
To ascertain whether Hex was being expressed from proviral insertions in tumors despite the absence of detectable GFP expression, we prepared mRNA from splenic tumors from these mice and analysed them by RT-PCR for provirus-derived Hex transcript. Expression of Hex from the proviral integrations could be detected in all tumors tested, but not in normal spleen mRNA from a control MSCV-IRES:GFP transplant recipient (Figure 6c) , confirming that the proviral integrations in MSCV-Hex:IRES:GFP transplant recipient tumors are producing Hex transcript.
Discussion
In this paper, we describe a model of Hex overexpression in hematopoietic cells that demonstrates the oncogenicity of Hex in murine lymphoid neoplasms. High levels of overexpression of Hex in murine hematopoietic precursor cells appear to inhibit the Although Lvis1 insertions are detectable in both B-cell and T-cell-derived malignancies in AKXD RI mice (Hansen and Justice, 1999) , MSCV-Hex:IRES:GFP virus-transduced C57BL/6 bone marrow recipients develop exclusively T-cell-derived lymphomas. The parental AKR/J strain from which AKXD RI mice are derived develop predominantly T-cell-derived malignancies (Mucenski et al., 1986) , suggesting that loci particular to some AKXD RI strains may predispose 
Analysis of Hex as a T-cell oncogene
A George et al these strains to B-cell malignancies when Hex is activated by proviral insertion. Variations in genetic background between C57BL/6 and AKXD RI strains may therefore account for the difference in tumor phenotype induced by Hex overexpression. Differences in the timing, level, or lineage specificity of Hex misexpression between our overexpression model and AKXD RI mice with Lvis1 insertions may also play a role in the onset of different types of neoplasms in these different models. Similar differences have been observed in the phenotypes of other oncogene overexpression models, including E2A-PBX1. While E2A-PBX1 translocations are found exclusively in B-cell leukemias in humans, E2A-PBX1 transgenic mice develop T-cell lymphomas and E2A-PBX1-transduced bone marrow recipient mice develop acute myeloid leukemia (Sawyers and Witte, 2001 ). The coexpression of Eg5 with Hex that is seen in AKXD tumors with Lvis1 insertions might also alter tumor origin (Hansen and Justice, 1999) . The T-cell lineage lymphomas that developed in the recipients of the Hex-transduced cells are remarkable for their apparent origin in bone marrow and the severity of bone marrow involvement. Bone erosion and spread to adjacent tissue is a uniform feature of the disease and is most unusual for mouse T-cell lymphomas. Precursor Tcell lymphoblastic lymphomas that regularly appear in strains such as AKR and C58 originate in the thymus and less than 10% exhibit bone marrow involvement which then is clearly secondary. Bone marrow involvement and extension seen in Hex-transplant recipient mice is quite similar to that seen in some mice infected with v-abl-expressing retroviruses (Rosenberg, 1994) .
The mechanisms by which Hex effects the neoplastic transformation of precursor T lymphocytes remain unclear. The long latency of tumor incidence in Hex virus-transduced bone marrow recipients indicates that Hex-misexpressing cells must accumulate additional mutations to undergo neoplastic transformation. While MSCV-Hex:IRES:GFP-transduced marrow recipient mice develop T-cell lymphomas, transgenic mice expressing Hex in developing thymocytes from the CD11a and Lck promoters fail to develop such tumors (Mack et al., 2002) , suggesting that the transformative events triggered by Hex misexpression occur prior to the stages at which the CD11a and Lck promoters are active. The oncogenic effects of Hex expression could be mediated by persistent low-level expression from Hex proviral insertions in multipotential cells in bone marrow or in committed precursors in bone marrow or thymus. The homeodomain of Hex is similar in amino-acid sequence to that of the proto-oncogene Hox11, which has been implicated in both T-and B-cell-derived lymphomas in transgenic and bone marrow transplant mice (Bedford et al., 1993; Hawley et al., 1997; Hough et al., 1998) . The two genes may act via common mechanisms to transform hematopoietic cells. The Hex protein interacts with the Jun family of transcription factor proteins and inhibits transcriptional activation by Jun protein-containing transcriptional complexes (Schaefer et al., 2001 ). The AP-1 transcriptional complex, which consists of a cJun/c-Fos heterodimer, and the JNK cascade, which acts through AP-1 phosphorylation, are modulators of T-cell activation and T-cell apoptosis (Behrens et al., 2001) . AP-1 has also been implicated as an effector of HoxB4-mediated proliferation and transformation by altering cell cycle dynamics (Krosl and Sauvageau, 2000) . The ectopic expression of Hex in hematopoietic cells may therefore lead to altered AP-1 activity and interfere with TCR signaling, thymocyte apoptosis, or cell cycle progression during T-cell development, all of which could contribute to arrested differentiation and neoplastic transformation of immature thymocytes or their progenitors. Finally, Hex and Scl have been shown to coordinately regulate each other and the downstream genes Gata1, Fli1, and Flk1 in zebrafish (Liao et al., 2000) . Scl has been implicated in human T-cell acute lymphoblastic leukemia (Goldfarb and Greenberg, 1994) . The forced expression of Hex may induce ectopic Scl expression in thymocytes or their precursors in bone marrow, resulting in the activation of neoplastic pathways induced by Scl.
The absence of blood cells expressing GFP at detectable levels in Hex virus-transduced bone marrow recipient mice suggests that high levels of expression of Hex in hematopoietic progenitor cells are toxic to these cells or otherwise inhibit their differentiation into hematopoietic lineages. Preliminary evidence from day 12 colony-forming unit-spleen (CFU-S) assays indicates that MSCV-Hex:IRES:GFP-transduced hematopoietic progenitor cells have a reduced capacity to form CFU-S colonies (data not shown), supporting the hypothesis that Hex misexpression in blood precursors inhibits their hematopoietic potential. A similar phenotype is seen in mice transplanted with Gata-2 virus-transduced bone marrow, although the mechanism of this inhibition is unclear in this case as well (Persons et al., 1999) . The forced expression of Hex in chicken blastoderm cells, which have many of the characteristics of multipotent hematopoietic cells, inhibits their transformation and proliferation (Jayaraman et al., 2000) . Hex has been implicated in the regulation of Scl and Flk-1 in zebrafish and of Flk-1 in human endothelial cells (Liao et al., 2000; Nakagawa et al., 2003) . Scl and Flk-1 are both Analysis of Hex as a T-cell oncogene A George et al critical in the onset of definitive hematopoiesis (Porcher et al., 1996; Shalaby et al., 1997) and alterations in their expression in hematopoietic stem cells by ectopic Hex activity could inhibit the hematopoietic potential of these cells.
In conclusion, our results demonstrate that Hex can induce the onset of hematologic malignancies when misexpressed in progenitor blood cells and indicate that normal hematopoiesis is sensitive to the level of Hex expression in progenitor cells. High levels of Hex expression in hematopoietic progenitors appear to inhibit differentiation into mature lineages while lower levels of misexpression result in the selective neoplastic transformation of precursor T lymphocytes. Our results contribute to the growing evidence that homeodomain transcription factors play important roles in normal 
Materials and methods
Mouse husbandry
Donor C57BL/6 CD45. 1 mice for bone marrow transplants were maintained in a level 4 barrier on autoclaved chow and acidified water under pathogen-free conditions. Recipient C57BL/6 CD45.2 mice were purchased from barrier stocks as needed and were maintained on autoclaved chow and acidified water at all times preceding and following bone marrow transplants.
Retroviral constructs and generation of infectious viral particles
The retroviral backbone used to derive all constructs is the MSCV construct, provided by Dr Robert Hawley (Hematopoiesis Department, American Red Cross) (Hawley et al., 1994) . The MSCV-Hex:IRES:GFP retroviral construct was generated by cloning a fragment containing the full-length Hex coding region with the endogenous Kozak sequence into the multiple cloning site of the pIRES2-EGFP vector (Clontech) and then subcloning the Hex-IRES-GFP cassette into the MSCV-PGK-Hph retroviral construct to replace the PGK-Hph cassette. The control MSCV-IRES:GFP construct was generated similarly by subcloning the IRES-GFP cassette from the pIRES2-EGFP vector into pMSCV-PGK-Hph. High-titer ecotropic virus particles were generated by transient transfection of the Phoenix ecotropic packaging cell line (ATCC) with MSCV-Hex:IRES:GFP or MSCV-IRES:GFP plasmid. Media from transfections were harvested 48, 72, or 96 h post-transfection and titered by flow cytometric analysis of transduced NIH3T3 cells for GFP fluorescence. Virus stocks used for bone marrow transductions ranged in titer from 1.3 to 1.8 Â 10 6 /ml.
Retroviral transduction of bone marrow cells
Bone marrow transductions with retroviral particles were performed essentially as described previously (Aster et al., 2000) . Bone marrow was harvested from 6-to 8-week-old male and female C57BL/6 CD45.1 mice 5 days after intravenous injection of 150 mg/kg 5-FU. Marrow cells were prestimulated for 24 h with 6 ng/ml murine IL-3, 10 ng/ml murine IL-6, and 100 ng/ml murine SCF (all from R&D Systems) in DMEM supplemented with 15% FBS, 2 mm l-glutamine, 100 U/ml penicillin, and 100 mg/ml streptomycin (all from Invitrogen) with WEHI3B-conditioned media added to 5%. Bone marrow cells were subjected to two rounds of spinoculation at 1000 g for 90 min at 301C in the media described above with the addition of polybrene (Sigma) to 4 mg/ml, HEPES buffer (Invitrogen) to 10 mm, and titer-matched Hex-IRES-GFP or IRES-GFP viral supernatant. Following the spinoculation, cells were incubated at 371C for 3 h and then resuspended in fresh prestimulation media and allowed to recover for 20 h. After the second recovery period, cells were washed and resuspended in PBS at a concentration of 2.5 Â 10 6 /ml in preparation for transplantation.
Transplantation of transduced bone marrow cells
Female C57BL/6 CD45.2 mice 8-to 12-week old, were subjected to 11 Gy of g-irradiation in a split dose (6 and 5 Gy with a 2-h recovery period in between). The mice were then injected retro-orbitally under anesthesia with 5 Â 10 5 bone marrow cells.
Flow cytometry
Single-cell suspensions were prepared from thymus and spleen by mincing and trituration. Bone marrow was flushed from leg bones and triturated to obtain single-cell suspensions. Peripheral blood samples were obtained by retro-orbital bleeds of anesthetized mice. Erythrocytes were lysed by incubation of single-cell suspensions in hypotonic lysis buffer (0.15 m NH 4 Cl, 0.017 m Tris base, pH 7.65) for 5 min. Cell suspensions were stained with the following antibodies obtained from BD Pharmingen: biotin-conjugated CD45.1 (A20) and CD8a (53-6.7); PE-conjugated CD4 (GK1.5); and FITC-conjugated CD90.2 (30-H12). Biotinylated antibodies were counterstained with streptavidin-PE or streptavidin-CyChrome. Samples were run on a Beckman-Coulter XL-MCL flow cytometer and were analysed using standard software provided with the flow cytometer. 
Histology
Tissue samples for histology were fixed in 10% buffered formalin, embedded in paraffin blocks, sectioned, and stained with hematoxylin and eosin. Bone samples were decalcified prior to embedding and sectioning.
Southern blot analysis
Genomic DNA was isolated from indicated organs and tumors using standard procedures. Genomic DNA (10 mg) was digested with 25 U of the indicated restriction enzymes and analysed by Southern blotting with radioactive probes synthesized by random-primer extension from the full-length Hex coding region, the full-length EGFP coding region, or a fragment from the TCR Jb2 locus.
RT-PCR analysis
PolyA-enriched RNA was purified from indicated organs using the PolyA-Pure kit (Ambion) following the manufacturer's instructions. A 0.5-1 mg measure of purified mRNA was used per sample for RT-PCR analysis. Reverse transcription of RNA was carried out using the Superscript kit (Invitrogen) using oligo-dT primers following the manufacturer's instructions. Second-strand synthesis and PCR amplification of cDNA was carried out using the following primer sets: for MSCV-Hex:RES:GFP-specific transcript, ATGCAGTTCC CGCACCCGGG (forward) and CCTTATTCCAAGCGG CTTCG (reverse), hybridizing to Hex coding region and IRES sequences, respectively; for Gapdh, TTCACCACCATG-GAGAAGGC (forward) and GGCATGGACTGTGGTCAT-GA (reverse).
Western blotting
Protein samples were prepared by mechanical disruption of cell pellets in lysis buffer (10 mm Tris-HCl pH 7.5, 150 mm NaCl, 5 mm EDTA pH 8, 1% Triton X-100) supplemented with a protease inhibitor cocktail (Boehringer-Mannheim). Samples were incubated on ice for 10 min and then centrifuged at 16 000 g for 5 min to clear debris. Protein (50 mg) from each sample was separated by electrophoresis in 10% Tris-Glycine acrylamide gels and transferred to nitrocellulose membranes. Membranes were hybridized overnight with rabbit anti-mouse Hex polyclonal antibody at a 1 : 3000 dilution and for 3 h with horseradish peroxidase-conjugated secondary anti-rabbit antibody (Amersham) at a 1 : 10 000 dilution, with washes after each incubation. Membranes were then incubated in luminescence reagent (Amersham) and exposed to film.
